(Q45733282)

15 December 2017

title

Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus (English)

1 reference

Mycobacterium tuberculosis

15 December 2017

main subject

0 references

Vaccinia virus

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author

Geoffrey Lilley Smith

3

object named as

Smith GL

1 reference

15 December 2017

Feng CG

1

1 reference

15 December 2017

Blanchard TJ

2

1 reference

15 December 2017

Hill AV

4

1 reference

15 December 2017

Britton WJ

5

1 reference

15 December 2017

publication date

1 December 2001

1 reference

Immunology & Cell Biology

15 December 2017

published in

1 reference

15 December 2017

volume

79

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

569-575

1 reference

Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Complications of smallpox vaccination, 1968.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Immunization of mice with mycobacterial culture filtrate proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Nonreplicating vaccinia vector efficiently expresses recombinant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Induction of bystander T cell proliferation by viruses and type I interferon in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1711.2001.01042.X

10.1046/J.1440-1711.2001.01042.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference